ArticleBiomedical engineering online2026
Predicting the diabetic foot in patients with type 2 diabetes mellitus based on machine learning.
Article in Biomedical engineering online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic foot (DF) is a severe complication of type 2 diabetes mellitus (T2DM), contributing to significant morbidity and healthcare costs globally. Early prediction and intervention are critical for preventing amputations and improving patient outcomes. However, traditional statistical methods lack the capacity to handle high-dimensional clinical data and identify optimal predictive features. This study aimed to develop and validate machine learning models for DF risk prediction using feature selection strategies based on binary logistic regression and information theory.
methodsA retrospective cohort of 1,179 patients (95 DF cases, 1,084 T2DM controls) was analyzed using clinical and biochemical data from 2019 to 2025. Three data sets were constructed: (1) original features; (2) features selected via binary logistic regression (F1); and (3) features selected via information-theoretic global learning (F2). Six models-extreme learning machine (ELM), kernel extreme learning machine (KELM), and their variants trained on the three data sets-were evaluated using fivefold cross-validation. Performance metrics included area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and computational efficiency.
resultsAge, blood-urea-nitrogen (BUN), homocysteine (Hcy), albumin (ALB), and fasting blood glucose (FBG) were identified as independent DF risk factors. The information theory-based KELM (IT-KELM) model achieved the highest AUC of 0.799 (sensitivity: 0.792 and specificity: 0.710) on F2, outperforming other models. Feature selection improved predictive accuracy while reducing computational time, with IT-KELM requiring 0.138 s for training and 0.0023 s for testing. The SHAP summary dot plot and bar chart revealed that the top five features contributing to the model were TP, RBC, ALB, BMI and HB.
conclusionsIntegrating information theory with KELM enhances DF risk prediction by optimizing feature subsets and leveraging nonlinear kernel mapping. The IT-KELM model demonstrates robust diagnostic performance and clinical feasibility for early DF screening. Future multi-center studies are needed to validate generalizability and refine model interpretability in real-world settings. This approach provides a cost-effective tool for precision medicine in diabetes care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.